Literature DB >> 8620842

Peptide YY expression is an early event in colonic endocrine cell differentiation: evidence from normal and transgenic mice.

B H Upchurch1, B P Fung, G Rindi, A Ronco, A B Leiter.   

Abstract

The hormone peptide YY is produced by endocrine cells in the pancreas, ileum and colon. We have previously shown that peptide YY is coexpressed in all four islet cell types in the murine pancreas when they first appear, suggesting a common peptide YY-producing progenitor. In the colon, peptide YY has been frequently identified in glucagon-expressing L-type endocrine cells. Characterization of colonic endocrine tumors in transgenic mice expressing simian virus 40 large T antigen under the control of the peptide YY gene 5' flanking region revealed tumor cells producing not only peptide YY and glucagon, but also neurotensin, cholecystokinin, substance P, serotonin, secretin, and gastrin. This suggested that multiple enteroendocrine lineages were related to peptide YY-producing cells. Subsequent examination of the ontogeny of colonic endocrine differentiation in nontransgenic mice revealed that peptide YY was the first hormone to appear during development, at embryonic day 15.5. Between embryonic days 16.5 and 18.5, cells expressing glucagon, cholecystokinin, substance P, serotonin, secretin, neurotensin, gastrin and somatostatin first appeared and peptide YY was coexpressed in each cell type at this time. Peptide YY coexpression continued in a significant fraction of most enteroendocrine cell types throughout fetal and postnatal development and into adulthood, with the exception of serotonin-producing cells. This latter population of cells expanded dramatically after birth with rare coexpression of peptide YY. These studies indicate that expression of peptide YY is an early event in colonic endocrine differentiation and support the existence of a common progenitor for all endocrine cells in the colon.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8620842     DOI: 10.1242/dev.122.4.1157

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  11 in total

1.  An enteroendocrine cell-based model for a quiescent intestinal stem cell niche.

Authors:  I R Radford; P N Lobachevsky
Journal:  Cell Prolif       Date:  2006-10       Impact factor: 6.831

2.  GATA6 is required for proliferation, migration, secretory cell maturation, and gene expression in the mature mouse colon.

Authors:  Eva Beuling; Boaz E Aronson; Luc M D Tran; Kelly A Stapleton; Ellis N ter Horst; Laurens A T M Vissers; Michael P Verzi; Stephen D Krasinski
Journal:  Mol Cell Biol       Date:  2012-06-25       Impact factor: 4.272

3.  The basic helix-loop-helix transcription factor BETA2/NeuroD is expressed in mammalian enteroendocrine cells and activates secretin gene expression.

Authors:  H Mutoh; B P Fung; F J Naya; M J Tsai; J Nishitani; A B Leiter
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

4.  Postnatal development of intestinal endocrine cell populations in the water buffalo.

Authors:  C Lucini; P De Girolamo; L Coppola; G Paino; L Castaldo
Journal:  J Anat       Date:  1999-10       Impact factor: 2.610

5.  PYY in the expanding pancreatic epithelium.

Authors:  Guoxun Liu; Sandrine Arnaud-Dabernat; Marcie R Kritzik; Ayse G Kayali; You-Qing Zhang; Nora Sarvetnick
Journal:  Endocrine       Date:  2006-08       Impact factor: 3.633

6.  Neurogenin3 is differentially required for endocrine cell fate specification in the intestinal and gastric epithelium.

Authors:  Marjorie Jenny; Céline Uhl; Colette Roche; Isabelle Duluc; Valérie Guillermin; Francois Guillemot; Jan Jensen; Michèle Kedinger; Gérard Gradwohl
Journal:  EMBO J       Date:  2002-12-02       Impact factor: 11.598

7.  Energy homeostasis and gastrointestinal endocrine differentiation do not require the anorectic hormone peptide YY.

Authors:  Susan Schonhoff; Laurie Baggio; Christelle Ratineau; Subir K Ray; Jill Lindner; Mark A Magnuson; Daniel J Drucker; Andrew B Leiter
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

Review 8.  Neuroendocrine neoplasia of the gastrointestinal tract revisited: towards precision medicine.

Authors:  Guido Rindi; Bertram Wiedenmann
Journal:  Nat Rev Endocrinol       Date:  2020-08-24       Impact factor: 43.330

9.  Origin and Genetic Background of Insulinomas.

Authors:  G. Rindi; M. E. Candusso; A. L. Marchetti
Journal:  Endocr Pathol       Date:  1999       Impact factor: 3.943

Review 10.  T antigen transgenic mouse models.

Authors:  Maria Teresa Sáenz Robles; James M Pipas
Journal:  Semin Cancer Biol       Date:  2009-02-14       Impact factor: 15.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.